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ABSTRACT
 cell cytokines play an important role in mediating airway inflammation in asthma. The predominance of a
Th2 cytokine profile, particularly interleukin (IL)-4 and IL-5, is associated with the pathogenesis and course
of asthma. The aim of this study was to test the hypothesis that a stressful life event alters the pattern of cy¬
tokine release in asthmatic individuals. Thirteen healthy controls and 21 asthmatic adolescents gave blood
samples three times over a semester: midsemester, during the week of final examinations, and 2—3 weeks af¬
ter examinations. Interferon- (IFN- ), IL-2, IL-4, and IL-5 were measured from supernatants of cells stim¬
ulated with PHA/PMA for 24 h. Cells from asthmatic subjects released significantly more IL-5 during the ex¬
amination and postexamination periods, whereas cells from healthy controls released significantly more IL-2
during the midsemester and examination periods, thereby indicating a bias for a Th2-like pattern in asth¬
matics and a Thl-like pattern in healthy controls. IL-4 and IL-5 production showed a marked decrease dur¬
ing and after examinations in healthy controls, whereas this decline was absent in asthmatics. The ratios of
IFN-y:IL-4 and IFN-y:IL-5 also revealed significant changes in the profile of cytokine release across the se¬
mester. These results indicate differential cytokine responses in asthmatics that may become pronounced dur¬
ing periods of cellular activation.
INTRODUCTION
Chronic airway inflammation is a characteristic featureof asthma, and it has been proposed that activated  helper
cells (Th) and their products, cytokines, play a central role in
the regulation of airway inflammation. Two functional subsets
of Th cells have been identified in the immune system: Thl
cells predominantly secrete interleukin-2 (IL-2) and interferon-
y (IFN- ) but little IL-4 and IL-5 and facilitate cell-mediated
immunity. Th2 cells, in contrast, produce IL-4, IL-5, IL-6, and
IL-10 predominantly but little IL-2 and IFN- and participate
in immediate hypersensitivity and allergic reactions.(l_3) Evi¬
dence suggests that the pathogenesis of asthma is associated
with a predominance of Th2-type cytokine production, and
these cytokines may be critical signals initiating and orches¬
trating the complex cellular events in airway inflammation and
hyperresponsiveness.<4'5)
IL-4 and IL-5 are two particularly important cytokines im¬
plicated in the pathogenesis of asthma. IL-4 is a  cell-stimu¬
lating and differentiating factor and an early signal for isotype
switching of  cells to produce immunoglobulin E (IgE).(6-7)
Induced production of IgE antibody is a fundamental feature of
allergic asthma. The major functions of IL-5 include the dif¬
ferentiation, maturation, and activation of eosinophils, as well
as the enhancement of eosinophil viability/8'
In allergic asthmatics, peripheral blood (PB) cells were found
to produce significantly more IL-4 and IL-5 than cells from nor¬
mal controls.<9) Similarly, PB cell cultures from atopic children
released higher levels of IL-4 but not    - .(10) It was demon¬
strated further that asthmatic individuals had higher percent¬
ages of Circulating  cells expressing IL-4 and IL-5 mRNA, a
cellular profile that was decreased with improved lung function
following glucocorticoid treatment/11'
Stress has been found to alter Thl and Th2 cytokine pro-
duction.(12~15) Stimulated PB cell cultures showed that acade¬
mic examination stress induced significant changes in the pro-
'College of Nursing, The Ohio State University, Columbus, OH 43210-1289.
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duction of IL-2 and IFN- . However, the effects of stress on
the levels of IL-4 and IL-5 have not been tested. In view of
long-standing speculation that stress exacerbates asthma symp-
toms,(16'17) changes in cytokine production are a potential mech¬
anism modulating the relationship between stress and asthma.
The goal of this study, therefore, was to test the hypothesis that
a stressful life event alters the pattern of cytokine release in
asthmatic adolescents. Thl (IL-2 and IFN- ) and Th2 cytokines
(IL-4 and IL-5) were investigated in relation to final examina¬
tion stress, comparing the levels and responsiveness to this
stressful life event between healthy controls and asthmatic in¬
dividuals. In addition, examination-induced changes in
eosinophils, IgE, and peak expiratory flow rates were evalu¬
ated.
SUBJECTS AND METHODS
Thirty-four students were recruited from two local high
schools in Madison, WI. The study protocol was approved by
the school district and Institutional Human Subjects Commit¬
tee, and consent forms were obtained from each student and a
parent. As can be seen in Table 1, subjects were divided into
healthy control, with no known health problems, and asthma
groups I and II, based on medications prescribed. The validity
of this subdivision was also supported by their IgE and blood
eosinophil levels (see Results). Most asthmatic students typi¬
cally used 2 puffs of ß-agonist or steroid inhalants or both twice
a day or as needed. Ninety-four percent of the subjects were
Caucasian (n = 32), and there was 1 African American and 1
Asian American. No significant differences were noted in age,
racial distribution, or gender among the three groups. Between
the two asthma groups, however, there were more female sub¬
jects in the Asthma I group than in the Asthma II group.
Procedures
Blood samples were collected three times across the fall se¬
mester of the school year: (1) midsemester in early December
(baseline), (2) during final examination week in mid-January
(Exam), and (3) again 2-3 weeks after final examinations (Post¬
exam). In each period, 5 ml of blood was collected into an
EDTA-containing vacutainer, and 10-20 ml of blood was col¬
lected into a heparinized vacutainer via routine venipuncture
between 7:30 and 8:45 am. EDTA-treated samples were sent to
a local laboratory for complete blood count with differentials.
Heparinized samples were processed for cytokine analyses.
Heparinized blood was layered onto Ficoll-Hypaque (1.077
sg, Sigma) and centrifuged at 450g for 30 min at ambient tem¬
perature. Mononuclear cells (MNC) at the interface between
plasma and Ficoll were carefully harvested and washed twice
with sterile phosphate-buffered saline (PBS without Ca2+,
Mg2+, pH 7.4, Gibco) and centrifuged at 450g for 10 min. The
cells were then resuspended with complete medium (RPMI
1640 supplemented with Hepes 25 mM, L-glutamine 2 mM,
gentamicin 50 ^g/ml, and 10% heat-inactivated fetal bovine
serum, FBS) to give a final cell concentration of 2 X 106/ml.
Cytokine induction and analyses
Using 24-well flat-bottom cell culture plates, 1 X 106 MNC
in 500 µ\ complete RPMI medium were cultured for 24 h at
37°C with 5% CO2 in the presence of phytohemagglutinin
(PHA, 5 /xg/ml) and phorbol myristate acetate (PMA, 10 ng/ml).
The PHA and PMA cocktail was found to induce maximal cy¬
tokine production from  lymphocytes/18' Culture supernatants
were then collected and stored in aliquots at
—
70°C until as¬
sayed.
IFN- , IL-2, IL-4, and IL-5 levels were determined by a stan¬
dard, two-step sandwich, enzyme-linked immunosorbent assay
(ELISA). Briefly, a microtiter plate was coated with a cytokine-
specific monoclonal antibody (mouse antihuman IFN- , Endo¬
gen; mouse antihuman IL-2, R&D Systems; and mouse anti-
human IL-4 and rat antimouse IL-5, PharMingen). Sample
supernatants were added to the plate, followed by the addition
of a biotinylated antibody directed against the specific cytokine
(polyclonal goat antihuman IFN- , R&D Systems; polyclonal
rabbit antihuman IL-2, PharMingen; and monoclonal rat anti-
human IL-4 and IL-5, PharMingen). Biotinylation of the poly¬
clonal antihuman IFN- and IL-2 was performed according to
manufacturer's instructions using an N-hydroxysuccinimide es¬
ter with a long chain sidearm (NHS-LC biotinylation kit, Pierce,
IL). The assay was developed with a streptavidin horseradish
peroxidase homopolymer and the substrate, trimethylbenzidine
(TMB). Cytokine levels were quantitated by comparison to a
standard curve generated from known concentrations of re-
combinant cytokine. The sensitivity for IL-2, IL-4, IL-5, and
IFN- was less than 25, 3, 3, and 100 pg/ml, respectively.
Blood analyses
A complete blood count with leukocyte differentials was de¬
termined at a local medical laboratory (General Medical Lab¬
oratories, Madison, WI). Plasma levels of IgE were measured
at the local hospital laboratory.
Table 1. Subject Characteristics
Healthy Control Asthma I Asthma II
Age (years)
Gender (VIM)
Asthma medication
Asthma duration (year)
13
15.8 d
9/4
None
0
0.6a
11
16.0 ± 0.6
7/4
Nonsteroidal
bronchodilator inhalant
7.9 ± 4.7
10
16.2 ± 0.8
3/7
Steroidal and
nonsteroidal inhalant
9.7 ± 5.2
aMean ± SD.
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Peak expiratory flow rate (PEFR)
Peak expiratory flow rate (PEFR) was measured in asthmatic
subjects only. Asthmatic subjects were provided with an As¬
sess Peak Flow Meter (HealthScan, Cedar Grove, NJ) and asked
to record peak flow readings daily for 2 weeks in each period.
Subjects were instructed to perform three peak flows at bed¬
time before taking asthma medications and to record the high¬
est value in the diary. Before this diary assignment, all subjects
were trained on how to use the flow meter correctly until they
demonstrated proficiency. The Assess Peak Flow Meter was
tested to be highly accurate and reproducible, with an average
flow error <0.25%/19>
Statistical analysis
Data were analyzed using SPSS statistical software. Re¬
peated measures analysis of variance (ANOVA) was employed
to analyze the significance of overall group differences, changes
in cytokine production, and cell responses across the three time
points (Baseline, Exam, and Postexam), and group X time in¬
teractions. When appropriate, one-way ANOVA was used to
determine group differences at each time, with specific con¬
trasts between healthy control and asthmatic groups. In addi¬
tion, correlational analyses were performed using Pearson prod¬
uct-moment correlations.
RESULTS
Cytokine and blood profiles of the groups
Cytokine Profile. The levels of cytokine production, as well
as the ratios of Thl/Th2 cytokines, were examined in asthmatic
and healthy control subjects. As can be seen in Table 2, there
were significant differences in the levels of IL-2 and IL-5 be¬
tween the healthy control and asthma groups. During the Base¬
line period, cells from healthy controls produced significantly
more IL-2 than did cells from asthmatics, particularly in com¬
parison with the asthma II group: F(2,31) = 3.49,  = 0.04
among the three groups; t(31) = 2.34,  = 0.026 between the
healthy control and combined asthma groups. In contrast, the
production of IL-5 was significantly higher in asthmatic sub¬
jects during the Postexam period, when both asthma groups had
more than threefold higher levels of IL-5 than control subjects:
F(2,23) = 4.72,/? < 0.02 among the three groups; t(23) = 3.07,
 
—
0.005 between the healthy control and combined asthma
groups. A similar pattern of significant differences was found
in the IL-2 and IL-5 responses during the Exam period between
healthy control and asthma groups (Table 2). IL-4 and IFN- 
production, however, was not different among the three groups.
In addition, the overall level of IL-4 released from the cells was
considerably lower than the levels of the other cytokines.
Because of the purported role of Th2 cytokines in the patho¬
genesis of asthma, we examined whether there were differences
between healthy and asthmatic subjects in the ratios of Thl vs.
Th2 cytokines. In this regard, the levels of IL-2 and IFN- were
examined with respect to IL-4 and IL-5. The ratio data were trans¬
formed by base 10 logarithm to generate a normal distribution
of the data. The IL-2:IL-5 ratio provided the greatest distinction
among the three groups. Repeated measures ANOVA indicated
a significant group difference, F(2,23) = 5.07,  < 0.02.
As illustrated in Table 3, specific contrasts between healthy
control and asthma groups showed that healthy controls had
significantly higher ratios of IL-2:IL-5 than asthmatic subjects
at all time points. Similarly, the ratios of    - :  -5 also were
significantly higher in healthy controls than in asthmatics dur¬
ing the Exam and Postexam periods. IL-2 and IFN- ratios with
respect to IL-4 levels, however, did not differ between groups.
Table 2. Cytokine Levels (pg/ml) from Supernatant Following 1-Day Culture of Cells with PHA/PMA Cocktail
Healthy
(n = 13)
Asthma I
(n = 11)
Asthma IL
( = 10)
Contrast (healthy
vs. asthma)
 
IL-2
Baseline
Exam
Postexam
IFN- 
Baseline
Exam
Postexam
IL-4
Baseline
Exam
Postexam
IL-5
Baseline
Exam
Postexam
13922 ± 1547a
12179 ± 1255
9437 ±1361
3143 ± 800
4044 ± 732
2712 ± 515
22.2 ± 3.5
17.3 ± 2.7
12.1 ± 2.8
842 ± 316
388 ± 125
293 ± 112
11510
9349
11736
2334
2546
2911
15.4
13.2
14.6
936
934
926
1249
771
1261
452
809
760
2.3
4.0
3.4
209
247
239
8965 ± 904
9246 ± 1333
9479 ± 1377
1696 ± 389
3640 ± 674
2564 ± 994
14.2
14.0
19.9
3.9
3.1
5.8
830 ± 182
926 ± 205
1083 ± 193
0.026b
0.047b
0.398
0.131
0.289
0.978
0.069
0.338
0.313
0.894
0.02 lb
0.005b
aMean ± SE.
bp values reflect significance of differences between healthy and combined asthmatic subjects at the level  < 0.05.
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Table 3. Th1/Th2 Cytokine Ratios from Supernatant Following 1-Day Culture of Cells with PHA/PMA Cocktail
Healthy(n = 13)
Asthma I
(n = 11)
Asthma II
(n = 10)
Contrast (healthy
vs. asthma)
 
IL-2: IL-5
Baseline
Exam
Postexam
IFN- : IL-5
Baseline
Exam
Postexam
IL-2: IL-4
Baseline
Exam
Postexam
IFN- : IL-4
Baseline
Exam
Postexam
1.52
1.73
1.66
0.60
1.19
1.06
2.85
2.97
2.82
1.92
2.43
2.24
0.15a
0.15
0.15
0.28
0.17
0.13
0.08
0.17
0.07
0.19
0.18
0.09
1.23
1.18
1.25
0.43
0.39
0.53
2.91
2.98
3.01
2.10
2.20
2.29
0.14
0.13
0.15
0.22
0.21
0.21
0.10
0.14
0.13
0.18
0.19
0.12
1.08
1.06
0.95
0.25
0.67
0.16
2.82
2.83
2.78
2.02
2.44
2.05
0.08
0.12
0.06
0.12
0.08
0.20
0.09
0.11
0.10
0.09
0.12
0.12
0.029b
0.00 lb
0.004b
0.344
0.003b
0.004b
0.86
0.74
0.59
0.49
0.61
0.61
"Mean ± SE.
hp values reflect significance of differences between healthy and combined asthmatic subjects at the level  < 0.05. Data are
transformed by base 10 logarithm.
Blood Analysis. As expected, plasma levels of IgE indicated
a significant overall group difference across the three time
points: F(2,28) = 4.24,  = 0.025, respectively. The average
levels of IgE were almost 10 times higher in asthmatics than in
controls: F(2,31) = 5.90,
 
= 0.007 for Baseline, F(2,30) =
3.63,
 
< 0.04 during Exams, and F(2,28) = 4.73,  = 0.017
during the Postexam period, respectively (Fig. 1). Asthma II
subjects also had higher mean levels of IgE than did asthma I
subjects at all time points. Similarly, both the overall percent¬
age and absolute number of eosinophils were significantly
higher in asthmatic subjects than in healthy controls: F(2,23) =
4.66,
 
= 0.02 and F(2,23) = 5.03,
 
= 0.015, respectively
(Fig. 1 ). The statistics for the absolute number of eosinophils
showed that the differences were most evident during the Base¬
line period.
Pulmonary Function. PEFRs were measured in asthmatic in¬
dividuals only. The two asthmatic groups did not differ in the
peak flow expiratory rates, although it should be reiterated that
the asthma II group required more medication to maintain their
lung function and had more males than the asthma I group. In
a subset of asthmatics who measured their baseline peak flow
rates in the morning and at bedtime (7 in the asthma I and 5 in
the asthma II groups), the decrease in flow rates at bedtime was
more prominent in asthma II subjects: -5.4 vs. -39.3 L/min.
Effect of examination stress
Cytokine Profile. Despite a number of group differences in
cytokine profiles between healthy controls and asthmatic sub¬
jects, we did not find significant changes in the production of
any single cytokine across the examination period. The most
notable changes over time were noted in the ratios of IFN-y:IL-
5 and IFN-rIL-4: F(2,44) = 5.00,  = 0.01, and F(2,44) =
6.40,
 
= 0.004, respectively. Healthy controls demonstrated a
marked increase in these cytokine ratios during the Exam pe¬
riod, which was sustained above baseline values during the
Postexam period, whereas this pattern was less clear in the two
asthma groups (Fig. 2).
Blood Profile. The levels of IgE and eosinophil numbers and
percent did not change significantly across the three time points.
Pulmonary Function. PEFRs were also not affected by the
examinations. The flow rates remained stable throughout the
school semester.
Correlations between cytokines and blood profiles
The two Thl-type cytokines, IL-2 and IFN- , were signifi¬
cantly correlated during the Baseline and Postexam periods (r =
0.48,
 
= 0.005, and r = 0.49,
 
= 0.005, respectively), but this
relationship weakened during the Exam period (r = 0.29,
 
=
0.11). In contrast, Th2-type cytokines, IL-4 and IL-5, were not
significantly correlated at any time point. Interestingly, how¬
ever, there were consistently high correlations between IL-4 and
IFN- across the three time points: r = 0.42,
 
< 0.02 during
Baseline, r = 0.37,
 
= 0.03 during the Exam period, and r =
0.52,
 
= 0.003 in the Postexam period, respectively.
Because of the known effects of IL-5 on eosinophil activity,
we also examined the relationship between IL-5 and
eosinophils. IL-5 levels were not significantly correlated with
either eosinophil number or percent at any time point. Simi¬
larly, IL-4 levels were not correlated with IgE. However, IgE
level was significantly correlated with eosinophil number dur¬
ing the Exam period, r = 0.42,  < 0.02.
DISCUSSION
The main goal of this study was to test the hypothesis that
a stressful event, such as final examinations, alters cytokine pro¬
duction in asthmatic adolescents. Unlike the previous reports
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12
-, 2.7
Baseline Exam
FIG. 1. Group differences in eosinophil percent (top) and IgE(bottom). Eosinophil percent differed significantly between the
healthy and asthma II groups during Baseline and Exam peri¬
ods. This group difference between healthy and asthma II sub¬jects extended to IgE levels at each time point.
of a significant reduction in IFN- and an increase in IL-2 pro¬
duction by lymphocytes during the examination period in med¬
ical students/12-14' we did not observe any significant changes
in the in vitro release of individual cytokines, IL-2, IFN- , IL-
4, and IL-5, that was restricted to the examination period. In¬
stead, the pattern of IL-5 production during both the Exam and
Postexam periods was found to differ between healthy and asth¬
matic subjects. Healthy subjects showed a considerable decline
in IL-5 production during the Exam and Postexam periods (/; =
0.055), whereas asthmatics did not show the examination-
induced decrease in IL-5. A similar pattern was found in IL-4
production. These decreases in the production of IL-4 and IL-
5 appear to largely account for the sustained increases in the
IFN^:IL-4 and the IFN-^IL-5 ratios in healthy subjects dur¬
ing the Exam and Postexam periods.
The clinical significance of this difference in cytokine pat¬
tern is not clear. Although it was not associated with a shift in
pulmonary function during the Exam period, it should be reit¬
erated that asthmatic subjects were allowed to continue their
asthma medications, both steroid and nonsteroid inhalants.
Baseline Exam Postexam
FIG. 2. Changes in the    - .  -4 ratio (top) and    - :  -
5 ratio (bottom) over time. Significant changes were found in
both Thl/Th2 ratios across the examination. For the IFN-^IL-
5 ratio, there was a significant group X time interaction, indi¬
cating a significantly different pattern of response over time
among the three groups.
throughout the study to evaluate changes in a normative situa¬
tion. Although the effects of these inhalants are mostly local,
one cannot completely rule out their possible effects on pe¬
ripheral blood cell function.
Overall, cytokine profiles of cells from asthmatic subjects
reflected a Th2-like predominance, whereas the cell response
from healthy control subjects was more indicative of a Thl-like
predominance. Specifically, cells from asthmatic subjects pro¬
duced significantly more IL-5 than did the cells from healthy
controls across the Exam and Postexam periods. In contrast,
proliferating cells from control subjects generated significantly
higher levels of IL-2 during the Baseline and Exam periods fol¬
lowing stimulation with the PHA/PMA cocktail. These patterns
were supported further when the balance between Thl and Th2
cytokines was evaluated. Healthy control subjects showed sig¬
nificantly higher ratios of IL-2:IL-5 as well as IFN-yIL-5 than
did the asthmatic students.
These findings are consistent with other studies reporting a
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predominant Th2-pattern in asthmatic subjects/20-22' Asthmat¬
ics, particularly during an acute, symptomatic period or with
severe asthma, typically present a strong bias for IL-4 and IL-
5 production when cells are obtained from either bronchoalve¬
olar lavage or PB. The overproduction of IL-4, however, may
be more a feature of an atopic state than a characteristic of
asthma/10' Although IL-4 can effectively induce the produc¬
tion of IgE/23' the correlations between peripheral blood IgE
production and IL-4 level have not been consistent/24' In our
study, IL-4 levels did not directly correlate with the plasma
level of IgE, nor did they correlate with IL-5 levels in the su¬
pernatant sample.
Higher IL-5 and eosinophil values in asthmatics appear to
support the purported relationship between IL-5 and eosinophil
function in the pathology of asthma. Other researchers have re¬
ported that the percentage of Th cells expressing IL-5 mRNA
was highly correlated with eosinophil counts in asthmatics/11'
Moreover, improvement in pulmonary function following an
oral glucocorticoid therapy coincided with reduced percentages
of IL-5 mRNA encoding cells, as well as decreased IL-5 se¬
cretion and eosinophil count/11-25' In our study, however, the
IL-5 levels induced from mononuclear cells were not directly
correlated in a linear manner with the blood eosinophil num¬
bers.
Although we did not find significant correlations between
pulmonary function, as measured by PEFR, and cytokine lev¬
els, this result may have been influenced by the relatively sta¬
ble and mild form of asthma. Asthmatic students in this study
appeared to be medically well managed, and the continued use
of daily medication may have mitigated against any exacerba¬
tion of symptoms during the stress of examinations. The influ¬
ence of stress may have been more evident if the medication
had been controlled and a more severe form of asthma had been
studied.
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